Loading...
OTCMMHTX
Market cap419kUSD
Dec 27, Last price  
0.00USD
1D
0.00%
1Q
-25.00%
Jan 2017
-98.48%
Name

Manhattan Scientifics Inc

Chart & Performance

D1W1MN
OTCM:MHTX chart
P/E
—
P/S
—
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
0.94%
Rev. gr., 5y
-18.84%
Revenues
0k
-100.00%
150,000000856,000633,0001,686,000687,000693,000652,000642,00064,000150,000142,000097,00050,00050,00050,0000
Net income
-1m
L-75.53%
-1,517,000-219,000-1,694,000-3,014,000-2,142,000-446,000-43,000-2,287,000-2,090,000-1,928,000-3,805,0008,012,000-6,108,0001,546,000-8,334,000-1,227,0004,314,000-3,665,000-4,760,000-1,165,000
CFO
-190k
L-45.56%
-445,000-751,000-331,000-537,000-700,000-406,000462,000-1,196,000-1,078,000-964,000-2,535,0003,415,000-4,558,000-791,000-682,000-316,000-388,000-421,000-349,000-190,000
Earnings
Mar 31, 2025

Profile

Manhattan Scientifics, Inc., a technology incubator, engages in the development and commercialization of life-enhancing technologies in the United States. It develops technologies in the areas of nano-technologies and nano-medicine. The company was formerly known as Grand Enterprises, Inc. Manhattan Scientifics, Inc. was founded in 1992 and is based in New York, New York.
URL
http://www.mhtx.com/
IPO date
May 24, 2000
Employees
1
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
50
0.00%
50
0.00%
Cost of revenue
704
732
739
Unusual Expense (Income)
NOPBT
(704)
(682)
(689)
NOPBT Margin
Operating Taxes
2,030
26
Tax Rate
NOPAT
(704)
(2,712)
(715)
Net income
(1,165)
-75.53%
(4,760)
29.88%
(3,665)
-184.96%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
60
110
130
Long-term debt
Deferred revenue
Other long-term liabilities
1,058
Net debt
(252)
(904)
(3,003)
Cash flow
Cash from operating activities
(190)
(349)
(421)
CAPEX
Cash from investing activities
102
332
300
Cash from financing activities
(20)
(40)
FCF
(83)
(2,024)
(376)
Balance
Cash
67
175
232
Long term investments
245
839
2,901
Excess cash
312
1,012
3,130
Stockholders' equity
(71,357)
(70,691)
(67,961)
Invested Capital
69,615
70,164
70,184
ROIC
ROCE
40.41%
129.41%
EV
Common stock shares outstanding
559,281
559,281
559,281
Price
0.00
-67.50%
0.01
-50.00%
0.02
-62.53%
Market cap
1,454
-67.50%
4,474
-50.00%
8,948
-64.66%
EV
2,260
4,628
7,003
EBITDA
(703)
(679)
(687)
EV/EBITDA
Interest
21
26
Interest/NOPBT